Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital — Pittsburgh, Pennsylvania

Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital is a clinical research site located in Pittsburgh, Pennsylvania, United States 15224-1791.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital has participated in 44 clinical trials with 3 currently active.

Therapeutic areas: Breast Cancer, Sarcoma, Colorectal Cancer.

Sponsors: NSABP Foundation Inc, Alliance for Clinical Trials in Oncology, ETOP IBCSG Partners Foundation.

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital?

Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital conducted?

Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital has 44 clinical trials on record, with 3 currently active. Their work covers Breast Cancer, Sarcoma, Colorectal Cancer.

Is Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital accredited by Crixeo Health?

Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.